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Summary
The contribution of anergy to silencing of autoreactive
B cells in physiologic settings is unknown. By com-
paring anergic and nonanergic immunoglobulin-
transgenic mouse strains, we defined a set of surface
markers that were used for presumptive identification
of an anergic B cell cohort within a normal repertoire.
Like anergic transgenic B cells, these physiologic
anergic cells exhibited high basal intracellular free cal-
cium and did not mobilize calcium, initiate tyrosine
phosphorylation, proliferate, upregulate activation
markers, or mount an immune response upon anti-
gen-receptor stimulation. Autoreactive B cells were
overrepresented in this cohort. On the basis of the fre-
quency and lifespan of these cells, it appears that as
many as 50% of newly produced B cells are destined
to become anergic. In conclusion, our findings indi-
cate that anergy is probably the primary mechanism
by which autoreactive B cells are silenced. Thusmain-
tenance of the unresponsiveness of anergic cells is
critical for prevention of autoimmunity.
Introduction
It was recently estimated that 50%–75% of newly pro-
duced B cells are autoreactive and must be silenced
by tolerance mechanisms (Nemazee, 1996; Wardemann
et al., 2003). Three distinct mechanisms by which autor-
eactive B cells are tolerized—clonal deletion, receptor
editing, and anergy—have been defined by using mice
transgenic for an autoreactive B cell antigen receptor
(BCR). Clonal deletion results in apoptotic death of au-
toreactive B cells early in B cell development (Nemazee
and Burki, 1989). Receptor editing is the result of re-ex-
pression of recombinase-activating genes in immature
B cells with concomitant rearrangement of new light-
chain genes resulting in a new immunoglobulin specific-
ity (Gay et al., 1993; Tiegs et al., 1993). Anergic B cells
are neither deleted nor edited; instead, they persist in
the periphery in an antigen-unresponsive state (Good-
now et al., 1988; Nossal and Pike, 1980). The relative
contribution of each of these mechanisms to physio-
logic immune tolerance is unknown. Recent evidence
*Correspondence: CambierJ@njc.orgindicates that clonal deletion occurs only when the po-
tential for receptor editing has been exhausted and
thus may not contribute substantially to physiologic tol-
erance (Halverson et al., 2004). The relatively small in-
crease in the frequency of edited cells seen when cell
survival is extended with B cell leukemia lymphoma 2
(Bcl-2) transgenes also supports a limited role for clonal
deletion in physiologic immune tolerance (Lang et al.,
1997). Anergy, in contrast, does not first require that all
receptor editing be futile (Hippen et al., 2005). Only
25% of mature peripheral B cells show evidence of
receptor editing (Casellas et al., 2001; Retter and Nema-
zee, 1998). Thus, we hypothesize that anergy may si-
lence many of the w75% of newly produced B cells
that are autoreactive and therefore is an important phys-
iologic mechanism for tolerance.
Anergy has been defined entirely in immunoglobulin-
transgenic mice in which all B cells are autoreactive
(Benschop et al., 2001; Goodnow et al., 1988). In such
mice, autoreactive B cells survive to populate the pe-
riphery and retain antigen-binding capacity yet are anti-
gen unresponsive. Anergy differs from clonal deletion
and receptor editing in two important ways. Anergy
can occur in both immature and mature B cells, and
anergy is reversible (Gauld et al., 2005). Given that aner-
gic cells are neither deleted nor edited, their persistence
raises the possibility that escape from anergy can result
in autoimmunity. Thus, the frequency with which the
large number of autoreactive immature B cells is toler-
ized via anergy becomes an important question.
To date, the only evidence for the existence of anergic
cells within a normal B cell repertoire has been indirect.
Glynne et al. (2000) used gene arrays to compare gene
expression in antigen-naive immunoglobulin-transgenic
B cells, anergic immunoglobulin-transgenic B cells, and
wild-type B cells. They found that wild-type B cells had
an expression profile intermediate between antigen-
naive and anergic B cells, suggesting that a substantial
portion of the wild-type B cells were anergic (Glynne
et al., 2000). Studies of Prkcd2/2 mice also demonstrate
the importance of anergy to immune tolerance. Although
clonal deletion and receptor editing are intact, mainte-
nance of anergy is defective in these mice, resulting in
autoimmune disease (Mecklenbrauker et al., 2002).
Anergic B cells do not upregulate activation markers,
proliferate, or secret immunoglobulin upon BCR aggre-
gation (Eris et al., 1994; Goodnow et al., 1988). This is
due to impaired signal transduction in anergic B cells.
In anergic cells, only a small number of substrates are ty-
rosine phosphorylated after BCR aggregation (Cooke
et al., 1994). Anergic cells also exhibit an elevated
basal-intracellular-calcium concentration ([Ca2+]i) but
no further increase in [Ca2+]i upon stimulation (Benschop
et al., 2001; Cooke et al., 1994; Healy et al., 1997). Finally,
anergic B cells have a markedly short half-life relative to
wild-type mature B cells (Fulcher and Basten, 1994). This
is due, at least in part, to an increased requirement for
B cell-activating factor of the TNF family (BAFF) for sur-
vival of these cells (Lesley et al., 2004). Defective signal-
ing and shortened lifespan prevent anergic cells from
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954Figure 1. Anergic B Cells Resemble Transitional 3 B Cells
Analyses of B220, CD93, IgM, and CD23 expression by splenocytes from ArsA1, a-HELtgHELtg, C57BL6 wild-type, and a-HELtg mice. CD93+
and CD932 B220+ cells were gated as shown for analysis of CD23 and IgM expression in order to allow enumeration of mature, T1, T2, and
T3 populations (Allman et al., 2001). Percentage of total B220+ cells in the mature (M) populations and transitional 1, 2, and 3 (T1, T2, T3) pop-
ulations are indicated.mounting an immune response. Determination of the
contribution of anergy to physiologic B cell tolerance
and autoimmune disease has been limited by the inabil-
ity to identify anergic B cells within the normal polyclonal
repertoire. We show here that a marker set thought
previously to identify late-transitional B cells actually
identifies anergic B cells within wild-type B cell compart-
ments. Expression of these markers in anergic immuno-
globulin-transgenic B cells was dependent on auto-
antigen exposure. In wild-type mice, the population
defined by these markers exhibited all the characteris-
tics of anergic cells defined by using immunoglobulin
transgenics. The size and short half-life of this popula-
tion imply that as many as 50% of immature B cells are
destined to become anergic. Identification of this aner-
gic population should allow studies of mechanisms of
anergy in normal mice and the role of anergy in mouse
models of autoimmunity.
Results
Anergic Immunoglobulin-Transgenic B Cells
Express a Transitional 3 (T3)-like Marker Set
We sought to define a marker set that could be used to
identify anergic B cells and approached this question
initially by comparing cell-surface-marker expression
by B cells from two anergic immunoglobulin-transgenic
mouse strains to those expressed by nonautoreactive
immunoglobulin-transgenic mice and wild-type mice.
The majority of B cells in both ArsA1 (Benschop et al.,
2001) and a-HELtgHELtg (hen-egg lysozyme) (Goodnow
et al., 1988) mice expressed CD93 (Norsworthy et al.,
2004) (Figure 1, Table 1), a marker previously identified
on developing B cells up to and including transitional 1
and 2 (T1 and T2) populations (McKearn et al., 1984;
Rolink et al., 1998). More recently, it was suggestedthat a third transitional population (T3) exists (Allman
et al., 2001). Interestingly, T3 cells express CD93 but
otherwise bear markers typical of mature follicular B
cells, e.g., CD23+ and IgMlow. In contrast to wild-type
mice that have approximately equal numbers of each
transitional population, anergic immunoglobulin-trans-
genic mice were found to have a single population of
uniformly CD23+, IgMlow, and CD93+ splenic B cells. T3
B cells and anergic B cells also expressed amounts of
CD24 heat-stable antigen (HSA) intermediate between
T2 and mature follicular B cells. T3 and anergic B cells
expressed extremely high amounts of IgD, greater than
mature follicular B cells. Additionally, although less in-
tense, ArsA1 and a-HELtgHELtg B cells also stained
with AA4.1, another CD93 antibody (Figure S1 in the
Supplemental Data available online). Finally, as shown
in Figure S2, 2-12Vk8 (a-Sm) and 125tg (a-insulin), ani-
mals considered by some to be anergic, do not exhibit
the T3 phenotype. Thus in some models, the surface
phenotype of T3 B cells and anergic B cells was identi-
cal, implying either that a cohort of anergic B cells are
blocked at the T3 stage of development or that assign-
ment of T3 cells as transitional is incorrect.
If T3 cells are a normal B cell developmental stage and
not an anergic population, BCR-transgenic mice with a
non-self-reactive specificity should have normal num-
bers of T3 B cells. To test this hypothesis, we examined
the size of the T3 population in mice that express high-af-
finity anti-HEL IgM, but not HEL (Goodnow et al., 1988)
and in the B1-8 Igk2/2mouse (Sonodaetal., 1997; Takeda
et al., 1993), a knockin of a VDJ region that encodes a re-
ceptor specific for nitrophenyl. As shown in Figure 1 and
Table 1, these mice had nearly normal numbers of CD93+
T1 and T2 B cells but virtually no T3 cells. This was not
due solely to an inability to downregulate membrane
IgM expression in immunoglobulin-transgenic B cells
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T1 T2 T3 Mature
C57BL6 3.3 6 1.2 (4.9 6 1.6) 3.0 6 0.5 (4.5 6 0.5) 3.4 6 0.7 (5.1 6 0.8) 44.1 6 2.0 (66.2 6 5.2)
ArsA1 0.7 6 0.1 (1.6 6 0.5) 2.6 6 0.3 (5.7 6 1.2) 32.8 6 7.9 (71.1 6 8.0) 7.5 6 5.3 (14.9 6 8.8)
a-HELtgHELtg 1.3 6 0.5 (5.7 6 3.7) 1.0 6 0.2 (4.2 6 2.0) 13.5 6 7.8 (48.2 6 13) 3.6 6 1.1 (13.9 6 3.1)
a-HELtg 4.8 6 2.3 (10.6 6 0.4) 2.4 6 1.1 (5.4 6 0.1) 0.6 6 0.2 (1.5 6 0.4) 25.1 6 11 (56.1 6 2.8)
B1-8 Igk2/2 8.9 6 5.8 (14.4 6 7.3) 1.5 6 0.3 (2.5 6 0.1) 1.0 6 0.6 (1.7 6 0.8) 27.2 6 4.5 (46.2 6 8.0)
The size (3106) of each transitional population (T1 = B220+ CD93+, CD232, and IgM++; T2 = B220+, CD93+, CD23+, and IgM++; T3 = B220+, CD93+,
CD23+, and IgM+) and the mature follicular (B220+ CD932, CD23+, IgM+, and IgM++) population in the indicated mouse strains is given6 standard
deviation (n = 3–5). Percentages of total B220+ cells 6 standard deviation are given in parentheses.because anti-HEL expression is appropriately downre-
gulated when HEL is present and the B1-8 transgene
isa knockin and thus subject to mechanisms that regu-
late normal endogenous heavy-chain gene expression.
Immunoglobulin transgenics typically exhibit acceler-
ated B cell development, but this is usually at the pre-B
cell to immature B cell transition, where gene rearrange-
ment is presumably rate limiting. Thus, the presence of
an immunoglobulin transgene is unlikely to accelerate
development through the T3 cell stage. These results
are consistent with the downregulation of IgM on T3 B
cells being an antigen-driven event. These data support
the hypothesis that the CD93+, IgMlow, and CD23+ phe-
notype does not mark a developmental stage but rather
defines antigen-experienced or anergic cells.
Loss of Autoantigen Signals Resulted
in Loss of CD93 Expression
We have previously shown in the ArsA1 mouse that ex-
posure to the monovalent hapten Ars tyrosine changes
the phenotype of B cells from anergic to naive (Ben-
schop et al., 2001). Recently, we reported that mainte-
nance of B cell anergy requires continuous exposure
of B cells to autoantigen (Gauld et al., 2005). If the T3
population represents an anergic population, we would
expect that termination of autoantigen stimulation
in vitro would result in loss of CD93. To test this possibil-
ity, we cultured ArsA1 B cells in media alone or media
plus monovalent hapten to dissociate autoantigen
(Gauld et al., 2005). After 18 hr, we determined CD93
expression (Figure 2A). The majority of ArsA1 B cells
lost CD93 when autoantigen was dissociated. Anergic
B cells cultured in media alone remained CD93+, and
wild-type B cells were unaffected by the presence of
hapten. As expected, Ars tyrosine did not affect the phe-
notype of B cells from the a-HELtgHELtg mouse (data
not shown).
We next examined whether termination of autoantigen
exposure in vivo changes the phenotype of B cells from
CD93+ to CD932. Splenocytes from a-HELtgHELtg mice
were labeled with a cytoplasmic fluorescent dye and
transferred into either HELtg or C57BL6 mice (Figure 2B).
Eighteen hours after transfer into C57BL6, many trans-
ferred cells were CD932. Loss of CD93 and upregulation
of IgM appear to occur concurrently because many of
the CD932 cells were also brighter for IgM (not shown).
In contrast, when transferred into a HELtg mouse, the
majority of B cells remained CD93+ and IgMlow, charac-
teristic of anergic B cells. These data indicate that main-
tenance of the T3 phenotype requires continuous anti-
gen exposure.Exposure of Mature B Cells to Autoantigen
Induced the T3 Phenotype
As a further test of the developmental intermediacy of T3
cells, we isolated a-HELtg splenocytes and transferred
them into HELtg or C57BL6 recipients. Whereas B cells
transferred into HELtg recipients quickly downmodu-
lated their surface IgM expression and upregulated
CD93, B cells transferred into C57BL6 mice retained
the mature CD932 phenotype (Figure 2B). Identical re-
sults were seen when the a-HELtg B cells were depleted
of CD93-expressing cells prior to transfer (data not
shown). These data provide further proof that T3 cells
are not intermediary between T2 and mature follicular
B cells.
T3 B Cells Were Found in Lymph Nodes
and Peripheral Blood
Reflecting their immaturity, transitional B cells are found
only in the spleen and peripheral blood, and not among
the more mature follicular B cells in lymph nodes (Loder
et al., 1999). Anergic B cells from autoreactive immuno-
globulin-transgenic mice can be found in the spleen,
lymph nodes, and peripheral blood (Cyster et al., 1994).
We examined peripheral-blood mononuclear cells,
inguinal-node lymphocytes, and splenocytes from
C57BL6 mice for the presence of T3 B cells (Figure 2C).
A distinct population of T3 B cells was clearly seen in
lymph nodes, further highlighting the differences be-
tween other transitional B cells and T3 B cells. Thus aner-
gic cells in the normal repertoire are not restricted to
specific lymphoid compartments.
BCR Signaling in T3 B Cells and Anergic Transgenic
B Cells Appeared Similarly Impaired
Like anergic transgenic B cells, T3 cells do not prolifer-
ate or secrete immunoglobulin in response to BCR stim-
ulation (Allman et al., 2001). To further explore the func-
tional similarity of T3 cells from normal and anergic
BCR-transgenic mice, we analyzed antigen-receptor
signaling. Anergic B cells have been shown previously
to be refractile to BCR stimulation as measured by cal-
cium mobilization and protein tyrosine phosphorylation
(Benschop et al., 2001; Cooke et al., 1994; Healy et al.,
1997). We compared changes in intracellular-free-
calcium concentration ([Ca2+]i) after BCR stimulation in
anergic ArsA1, and mature follicular and transitional
populations of wild-type mice. The T3 population from
wild-type mice exhibited a [Ca2+]i response comparable
to that observed in anergic ArsA1 B cells and distinct
from that seen in other transitional populations (Fig-
ure 3A). The slight residual responsiveness seen in the
Immunity
956Figure 2. Exposure to Autoantigen Is Necessary and Sufficient for Expression of T3 Markers
(A) Splenic B cells from wild-type or ArsA1 mice cultured for 18 hr in media alone or media with 1024 M Ars-tyrosine (hapten). Analysis of CD93
and B220 expression is shown. The percentage of total B cells in the transitional (CD93+) or mature (CD932) populations is indicated.
(B) From a-HELtg or a-HELtgHELtg mice, 107 splenocytes were labeled with Cell Tracker Blue and transferred into C57BL6 or HELtg mice by tail-
vein injection. Splenocytes were harvested 18 hr later and analyzed for CD93, B220, and IgM. B220 and CD93 staining of Cell Tracker Blue+ cells
are shown. In the inset cytogram, CD93+ B cells are further divided into T1 + T2 and T3 populations on the basis of IgM expression. Percentages
of total Cell Tracker Blue+ B cells in the mature follicular (M) and marginal zone (Mz), transitional 1 and 2 (T1 and T2), and transitional 3 (T3) pop-
ulations are indicated.
(C) Flow-cytometric analysis of splenocytes, peripheral-blood mononuclear cells, and inguinal lymph-node cells from C57BL6 mice for B220 and
CD93 expression. CD93+ and CD932 B cells were subsequently analyzed for CD23 and IgM expression. Percentage of total B cells in the mature
(M) populations and transitional 1, 2, 3 (T1, T2, T3) populations are indicated within each gate.T3 cells was likely due to an inability to completely ex-
clude all mature and T2 cells from this population. The
blunted calcium response was not due to the decreased
IgM expression on the T3 and anergic populations be-
cause mature (CD932) cells gated for equivalent IgM
expression (mature IgMlow) mounted a robust calcium
flux after BCR stimulation.
Anergic transgenic B cells exhibit a characteristically
blunted BCR-mediated protein-tyrosine-phosphoryla-
tion response with increased basal phosphorylation of
Erk (Extracellular-signal-regulated kinase) (Healy et al.,
1997) and Dok-1 (Downstream of kinase) (K.T.M. and
J.C.C., unpublished data). Analysis of protein tyrosine
phosphorylation showed a similar pattern in T3 B cells
(Figure 3B). T1 and T2 populations, when compared to
mature follicular B cells, exhibited enhanced tyrosine
phosphorylation similar to previously reported re-
sponses of immature B cells (Benschop et al., 1999).
However, like anergic immunoglobulin-transgenic B
cells, T3 B cells showed elevated basal Erk and Dok-1
phosphorylation relative to mature follicular cells but
virtually no induced protein tyrosine phosphorylation.
Although T3 B cells did not respond to BCR stimulation,
they did exhibit robust tyrosine phosphorylation after
pervanadate treatment. Thus, although all transitional
B cells have been shown not to proliferate, upregulate
activation markers, or secrete immunoglobulin in re-
sponse to BCR aggregation (Allman et al., 2001), only
in the T3 B cells was this associated with impaired signal
transduction as seen in anergic immunoglobulin-trans-
genic B cells.
In Vivo Fate and Immunogen Responsiveness
of T3 Cells Is Consistent with Anergy
The in vivo responsiveness and developmental fate of
T3 B cells has not been examined. Given their impairedin vitro responses, we would expect that all of the tran-
sitional B cells would fail to respond to immunization.
However, if T3 B cells were really a late-transitional pop-
ulation, we would expect them to contribute to the ma-
ture B cell pool more rapidly than T2 B cells and be
capable of mounting an immune response. Alterna-
tively, if the T3 B cells are anergic and not a develop-
mental intermediate, then the T2 B cells should con-
tribute to the mature pool more readily. In order to
adequately test this hypothesis, it was necessary to
measure a polyclonal response to BCR stimulation be-
cause each transitional population likely has a different
repertoire in which the frequency of cells specific for
a given antigen varies. Therefore, we purified T1, T2,
T3, and mature follicular B cells, transferred them into
Igk2/2 mice (Takeda et al., 1993), and immunized them
with goat anti-mouse k antibodies. This stimulus in-
duces a polyclonal antibody response aided by k and
goat-Ig-specific T cells. Consistent with in vitro data,
only mature follicular B cell mounted a strong immune
response (Figure 4A).
We also examined the developmental fate of these
cells after adoptive transfer. We labeled purified transi-
tional or mature follicular B cells with carboxyfluorescein
succimidyl ester (CFSE) and transferred them into
C57BL6 mice, then examined their developmental fate
60 hr later. Whereas transferred T3 cells remained
CD93+, most transferred T2 B cells lost CD93 expression
(Figure 4B). Although this analysis is complicated in all
cases by poor recovery of transferred cells, T3 B cells
clearly contributed less readily to the mature pool than
T2 B cells. Indeed, unlike the T2 population, the majority
of T3 B cells still had the T3 phenotype 60 hr after trans-
fer (Table 2). These data provide further evidence that T3
cells are not a developmental intermediate, but rather
a distinct anergic population.
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(A) Analysis of [Ca2+]i in ArsA1 (orange) and wild-type mature (black), T1 (blue), T2 (green), and T3 (red) B cells after stimulation with anti-m. Mature
B cells were also gated for an IgMlow population (purple) expressing equivalent IgM to the T3 or ArsA1 B cells.
(B) Immunoblot of sorted T1, T2, T3, mature (M) and a-HELtgHELtg (4 3 5) B cells stimulated for 3 min with anti-m, then probed with anti-phos-
photyrosine and subsequently for phospho-Erk, total Erk, phospho-Dok and total Dok. Protein-tyrosine-phosphorylation response to pervana-
date treatment is also shown. Numbers indicate Dok and Erk1 phosphorylation normalized to mature resting amounts and loading controls.High Frequency of Autoreactive B Cells
in the T3 Population
If the T3 population is anergic, it should contain a high
frequency of autoreactive cells. However, if it is a late-
transitional population it should have a frequency inter-
mediate between T2 and mature follicular B cells be-
cause autoreactivity declines from a very high frequency
as immature (T1) B cells become mature follicular B
cells. We wanted to determine the relative frequency
of autoreactive cells within these populations. We
were unable to make hybridomas from T3 cells or aner-
gic transgenic cells at a reasonable frequency, and were
concerned that any contamination of our sorted T3 pop-
ulation with mature cells that more readily formed hy-
bridomas would strongly bias our results. Therefore,
we sorted transitional and mature follicular B cells, stim-
ulated them with lipopolysaccharide (LPS) to induce im-
munoglobulin secretion, and assessed the frequency of
IgM-autoantibody-secreting cells by ELIspot. Although
the LPS responsiveness of anergic B cells is controver-
sial (Adams et al., 1990; Chu et al., 2002; Noorchashm
et al., 1999; Phan et al., 2003; Pike et al., 1983; Tsao
et al., 1993), under these conditions in which antibody
secretion was detected after 36 hr of LPS treatment, re-
covery of viable cells and frequency of IgM-secreting
cells was similar among all populations. This included
a-HELtgHELtg B cells used as a control to test for LPSresponsiveness in anergic B cells. We found up to a 5–
10-fold-higher frequency of B cells reactive to single
stranded DNA (ssDNA) or Smith antigen (Sm) in stimu-
lated T3 populations than in T2 and mature follicular B
cell populations (Figure 5). Although not statistically sig-
nificant (p = 0.7), there was a trend for the T3 population
to be even more autoreactive than the T1 population,
a population already previously reported to be highly
autoreactive (Wardemann et al., 2003). The frequency
of cells reactive to double-stranded DNA (dsDNA), chro-
matin, or cardiolipin in the T3 population was less than
2-fold above that in mature follicular cells (not shown).
Thus the T3 population is enriched in cells reactive to
certain autoantigens.
Gene Expression in T3 B Cells
If T3 B cells are a physiologic anergic B cell cohort, we
would expect their gene-expression profile to mirror
that of anergic immunoglobulin-transgenic B cells. The
transcriptional profile of anergic B cells has been previ-
ously explored by using gene arrays, and a remarkably
small set of genes was noted to be upregulated when
anergic a-HELtgHELtg B cells were compared to anti-
gen-naive a-HELtg B cells (Glynne et al., 2000). An
even smaller set of genes was downregulated in anergic
cells. We chose to examine expression of seven genes
whose expression was most strongly increased in
Immunity
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(A) Response to immunization with goat anti-mouse k light chain as measured by serum k+ Ig. Mean responses are indicated with black bars.
(B) CD93 levels on sorted cells prior to transfer and on B cells recovered from spleens 60 hr after transfer into C57BL6 mice. One million CFSE-
labeled, sorted mature, T2, or T3 B cells were transferred via tail-vein injection and detected among recipient splenocytes on the basis of CFSE
staining.anergic B cells: Egr1 (early growth response 1), Egr2
(early growth response 2), Nab2 (Ngfi-A binding protein
2), Pcp4 (Purkinje cell protein 4), Cd72, Crisp3 (cysteine-
rich secretory protein 3), and Nrgn (neurogranin). We
also examinedNfatc2 (nuclear factor of activated T cells,
cytoplasmic, calcineurin-dependent 2) and Evi2a (eco-
tropic viral integration site 2a), which were downregu-
lated in anergic cells. We were unable to confirm the
previously reported differences in expression between
anergic a-HELtgHELtg B cells and antigen-naive a-
HELtg B cells for Cd72, Nfatc2, and Evi2a. Furthermore,
when anergic a-HELtgHELtg B cells were compared to
mature follicular B cells from wild-type mice instead of
antigen-naive a-HELtg B cells, the differences in expres-
sion of Crisp3, Pcp4, and Egr1also disappeared. Wecompared the expression of the remaining genes in tran-
sitional, mature follicular, and anergic transgenic B cells.
Thea-HELtgHELtg B cells expressed increased amounts
of Egr2, Nab2, and Nrgn relative to follicular cells, con-
firming Glynne’s findings. Importantly, T3 B cells also ex-
pressed increased amounts of these genes, consistent
with their being anergic. However, the ArsA1 B cells did
not exhibit increased expression of these genes, imply-
ing that there may be no universal anergic transcriptome.
Discussion
We present evidence that the CD93+, CD23+, and IgMlow
cell population found in normal mice is not a transitional
population. Although T3 B cells, like transitional B cells,Table 2. Developmental Fate of Transferred Cells
Recovered T1 T2 T3 Mature MZ
Transferred
T1 0.77 6 0.04 (13.5 6 1.2) 0.84 6 0.09 (14.6 6 1.0) 0.49 6 0.16 (8.6 6 2.4) 2.24 6 0.05 (39.2 6 0.6) 1.38 6 0.04 (24.2 6 1.6)
T2 0.22 6 0.01 (2.2 6 0.5) 1.88 6 0.61 (18.3 6 2.5) 1.68 6 0.42 (16.5 6 0.9) 6.07 6 0.97 (60.0 6 2.1) 0.30 6 0.01 (3.0 6 0.7)
T3 0.12 6 0.02 (1.5 6 0.7) 0.96 6 0.28 (10.8 6 0.3) 4.20 6 1.66 (46.1 6 3.8) 3.52 6 0.86 (39.7 6 3.1) 0.18 6 0.08 (2.0 6 0.2)
Mature 0.05 6 0.03 (0.4 6 0.3) 0.54 6 0.04 (4.2 6 0.7) 1.10 6 0.30 (8.4 6 0.3) 11.05 6 2.72 (84.8 6 1.1) 0.27 6 0.01 (2.1 6 0.4)
Sixty hours after tail-vein injection into C57BL6 mice of 106 CFSE-labeled cells of the indicated population, the number of CFSE+ cells recovered
per spleen (3103) in each population is given6 standard deviation (n = 3). Percentages of total recovered cells6 standard deviation are given in
parentheses. Marginal-zone B cells (MZ = B220+, CD932, CD232, IgM++) were also enumerated. Results are representative of three experiments.
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Expression within the T3 Population
(A) Sorted T1 (red), T2 (blue), T3 (green), and
mature follicular (white) B cells from C57BL6
mice and bulk a-HELtgHELtg (black) B cells
were incubated with LPS to induce immuno-
globulin secretion. Cells were counted and
IgM-secreting and autoantibody-secreting
cells were enumerated by ELIspot assays
done in triplicate. Number of viable cells per
culture and percentage of viable cells secret-
ing IgM are shown. Autoantibody results are
expressed as percentage of IgM-secreting
cells with autoantigen reactivity. Error bars
reflect standard deviation. * p < 0.05.
(B) Total RNA from sorted T1 (red), T2 (blue),
T3 (green), mature follicular (white), a-HELtg
(purple), a-HELtgHELtg (black), and ArsA1 (yellow) B cells was used to measure relative transcript expression by real-time PCR. Expression
of Gapdh in each cell type is shown relative to that in mature follicular B cells. Expression of Egr2, Nab2, and Nrgn is shown relative to that in
mature B cells and normalized to Gapdh levels. Error bars reflect standard deviations of assays done in triplicate. Results are representative
of two experiments.did not proliferate, upregulate activation markers, or se-
crete immunoglobulin in response to BCR stimulation,
they were clearly not transitional. Immunoglobulin-
transgenic mice whose B cells are antigen naive devel-
oped normal numbers of T1, T2, and mature B cells with-
out a detectable T3 population. Mutations that prevent
optimal BCR signaling, e.g.,Btk2/2 (Bruton’s tyrosine ki-
nase) (Allman et al., 2001), Cd192/2, or Plcg22/2 (phos-
pholipase C, gamma 2) (Bell et al., 2004), result in loss
of T3 cells without affecting T2 or mature populations.
This is inconsistent with T3 B cells’ being a developmen-
tal intermediate, but consistent with a dependence of
their existence on autoantigen-driven BCR signaling.
The induction of the T3 phenotype in mature a-HELtg
B cells upon transfer into HELtg mice is also consistent
with this explanation. The presence of T3 B cells in
lymph nodes stands in stark contrast to the distribution
of other transitional populations. T3 B cells also did not
give rise to mature follicular B cells as well as T2 B cells
in cell-transfer experiments. Tyrosine phosphorylation
and calcium mobilization downstream of BCR signaling
in T3 B cells was quite different from that seen in transi-
tional B cells. Finally, T3 B cells were more autoreactive
than T2 or mature follicular B cells. It is difficult, if not
impossible, to imagine a mechanism by which the fre-
quency of autoreactive cells among T2 B cells would in-
crease as they develop into T3 cells, only to fall again as
the cells become mature B cells. The authors who orig-
inally identified the T3 population have now shown that
T2 B cells can contribute directly to the mature follicular
pool without passing through the T3 stage (Srivastava
et al., 2005). Indeed there is no evidence that T3 B cells
become mature B cells. T3 B cells were originally pro-
posed to be transitional on the basis of their short half-
life and their expression of CD93 (Allman et al., 2001).
Given that both of these features are also characteristics
of anergic B cells, it seems more likely that T3 B cells
represent an anergic population.
T3 B cells exhibit every hallmark of anergic B cells yet
defined by using autoreactive immunoglobulin-trans-
genic mice. T3 B cells do not proliferate, upregulate ac-
tivation markers, or secrete immunoglobulin in response
to BCR stimulation (Allman et al., 2001). This appears to
be due to impairment in calcium and phosphotyrosine-mediated signaling in T3 B cells, impairment that is iden-
tical to that seen in anergic immunoglobulin-transgenic
B cells but is not seen in other transitional populations.
Like anergic immunoglobulin-transgenic B cells, T3 B
cells also have elevated basal intracellular calcium and
phosphorylation of Erk and Dok-1. The response to im-
munization, the developmental fate, and the autoreac-
tivity of T3 B cells are consistent with anergy but incon-
sistent with a transitional phenotype. Finally, T3 B cells
have an in vivo half-life of 4 days (Allman et al., 2001),
identical to that of anergic B cells in the presence of
competing nonautoreactive B cells (Fulcher and Basten,
1994). In light of our evidence that T3 B cells are not tran-
sitional and their similarity to anergic immunoglobulin-
transgenic B cells, we propose that this population
should be renamed anergic population 1 (An1) B cells.
Taken together, these data suggest an important role
for anergy in physiologic B cell tolerance. The size of the
An1 population varies among strains but ranges from 1
to 5 3 106 cells per spleen, of which approximately
half (0.5 to 2.5 3 106) are replaced every 4 days (Allman
et al., 2001). Thus, up to 50% of the 5 3 106 new B cells
estimated to arrive in the spleen every 4 days (Allman
et al., 2001; Rolink et al., 1998) are destined to become
anergic. Prior to this work, the relative contribution of
anergy to B cell immune tolerance was unknown. The in-
cidence of autoimmunity in Prkcd2/2 mice in which
anergy is impaired implied an important role (Mecklen-
brauker et al., 2002). In addition, gene-array compari-
sons of anergic, antigen-naive, and mature B cells sug-
gested a substantial frequency of anergic cells within
the wild-type repertoire (Glynne et al., 2000).
The original gene-array experiments, which com-
pared expression in a-HELtgHELtg and a-HELtg B cells,
found very few genes whose regulation was affected by
anergy (Glynne et al., 2000). The authors of this work ac-
knowledged that in order to detect differences in gene
expression, they had to employ statistical methodology
that carried a risk of false positives. Of the nine genes we
examined, we were unable to validate changes in ex-
pression in three: Cd72, Evi2, and Nfatc2. Furthermore,
when expression in a-HELtgHELtg B cells was com-
pared to mature follicular polyclonal B cells rather than
total B cells from naive a-HELtg spleens, no differences
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960in expression of Crisp3, Pcp4, and Egr1 were seen. Sim-
ilar results were seen for Crisp3 in the gene-array exper-
iments and led those authors to conclude, as we have,
that a substantial portion of the wild-type repertoire re-
sults in anergy. We were able to confirm increased ex-
pression of Egr2, Nab2, and Nrgn in a-HELtgHELtg
and An1 B cells. Egr-2 is a transcription factor induced
by increased intracellular calcium and known to be re-
quired for T cell anergy (Glynne et al., 2000; Harris
et al., 2004). It is therefore not surprising that its expres-
sion is also increased in anergic B cells. Nab2 expres-
sion is induced by Egr-2 and inhibits its function, thus
creating a feedback loop (Mechta-Grigoriou et al.,
2000; Svaren et al., 1996). Neurogranin has been studied
primarily in neurons, where it displaces calcium from
calmodulin, thus raising [Ca2+]i and modulating cal-
cium-dependent signals. It plays a similar role in T cells,
where it also serves as a proapoptotic factor (Devireddy
and Green, 2003; Huang et al., 2004). Its expression in
anergic cells may serve to maintain increased [Ca2+]i.
Most surprising to us was the lack of correlation be-
tween altered gene expression in ArsA1 anergic B cells
and An1 or a-HELtgHELtg B cells. Egr2, Nab2, and
Nrgn expression is regulated by [Ca2+]i. We postulate
that the higher-affinity interactions with the autoantigen
in a-HELtgHELtg B cells may result in changes in gene
expression not seen in the ArsA1 B cells, which have
low affinity for self antigens. Many of the genes found
to be upregulated in a-HELtgHELtg B cells may be upre-
gulated because of the unusually robust phosphoryla-
tion of Erk seen in these cells. We have recently shown
that many features of anergy are lost within minutes of
autoantigen dissociation, implying that a specific tran-
scriptional program is not required for anergy (Gauld
et al., 2005). At the very least, these data suggest that
there is no universal anergic-B cell transcriptome. In
this regard, B cell anergy may differ from T cell anergy,
in which activation of NFAT and FOXp3 (Forkhead box
protein 3) induces a distinct transcriptional program. In-
deed, T cell anergy and its associated transcriptional
program can be induced solely by chronically increasing
intracellular calcium with ionomycin. Although ionomy-
cin can similarly activate NFAT in B cells, it has not
been shown to induce anergy, and anergic B cells do
not express FoxP3 (Y. Wang and J.C.C., unpublished
data).
It is important to note that An1 cells may not represent
the only anergic B cell population in wild-type mice.
Whereas a-HELtgHELtg, ArsA1, and 3H9 (Fields et al.,
2005) (a-dsDNA) anergic B cells express CD93, anergic
B cells from other transgenic models (a-insulin and
a-Sm) do not. However, in the latter models, BCR ex-
pression is less downregulated and B cells are not
excluded from follicles (Acevedo-Suarez et al., 2005;
Borrero and Clarke, 2002). Therefore, an additional aner-
gic population, currently indistinguishable from mature
CD932 B cells, may exist in wild-type mice. Further-
more, other anergic B cells may be lost at earlier stages
in development. In the a-HEL knockin model (swHEL),
where autoreactive B cells compete with nonautoreac-
tive B cells, the anergic cells have been reported to be
blocked in their development at the ‘‘late’’ T2 stage
with additional loss of autoreactive cells at earlier stages
(Thien et al., 2004). This work classified transitional cellson the basis of the criteria of Loder et al. (1999) and not
the criteria of Allman et al. (2001). It is now clear that
these two systems do not identify equivalent T2 popula-
tions (Srivastava et al., 2005). Furthermore, the swHEL B
cells were shown to be IgMlow, but T2 B cells by either
classification scheme are typically IgMhi (Allman et al.,
2001; Loder et al., 1999). We suspect that if analyzed
by the Allman criteria, these swHEL B cells would be
classified as T3 cells (CD23+, CD93+, IgMlow). Thus, the
proportion of immature autoreactive B cells that are
silenced by anergy may be underestimated by our work.
The temporary preservation of large numbers of auto-
reactive B cells in the periphery carries substantial risks
for the organism. This is particularly true given the
reversability of anergy by autoantigen removal or TLR
ligand stimulation. If these cells escape anergy and are
subjected to self-affinity maturation, autoimmunity will
likely result. With the identification of the An1 popula-
tion, we can now begin to examine the role that break-
down of anergy plays in mouse models of autoimmune
disease. We can also begin to examine the biochemical
mechanisms by which anergy is induced and main-
tained, as well as the conditions in which BCR-antigen
interactions lead selectively to anergy.
Experimental Procedures
Mice
Mice 6–12 weeks old were used for all experiments. Mice were bred
in the Biologic Resource Center at the National Jewish Medical Re-
search Center. a-HELtgHELtg, ArsA1, and B1-8 Igk2/2 mice have
been previously described (Benschop et al., 2001; Goodnow et al.,
1988; Sonoda et al., 1997; Takeda et al., 1993). All mice were on a
C57BL6 background. Animal use was approved by the National Jew-
ish Medical Center Institutional Animal Care and Use Committee.
Cell Culture
Bulk splenic ArsA1 and C57BL6 B cells were purified by CD43-me-
diated negative selection with an AutoMacs (Miltenyi Biotechnol-
ogy). Purified B cells were cultured in improved modified Dulbecco’s
medium (IMDM) supplemented with 5% fetal-calf serum (FCS), 10
mM glutamine, 10 mM HEPES, 0.5 mg/ml gentamicin, and 5 3 1025
M 2-mercaptoethanol (2-ME). For hapten-induced dissociation of
autoantigen, ArsA1 B cells were cultured for 18 hr in 1024 M Ars-
tyrosine-containing media.
Antibodies, Immunofluorescence Analysis, and Cell Sorting
Cells were resuspended in phosphate-buffered saline (PBS) con-
taining 1% FCS and 0.1% sodium azide and incubated with an opti-
mal amount of biotinylated or directly labeled antibodies. Antibodies
directed against the following molecules were used: CD23 (B3B4,
BD Pharmingen), B220 (RA3-6B2, BD Pharmingen), IgM (rabbit poly-
clonal, Jackson Labs), IgM (R6-60.2 BD Pharmingen), CD93 (493,
Gift of A. Rolink), and AA4.1 (BD Pharmingen). The 493 antibody
was biotinylated in our lab with standard techniques because the
biotinylated antibody generally gave better staining. Fab fragments
of anti-IgM (b-7-6) were made by standard techniques in our lab.
Cells were incubated for 30 min at 4C and washed twice in PBS
containing FCS and azide. In the case of biotinylated reagents, cells
were incubated as before with streptavidin-fluorescein isothio-
cyanate (SA-FITC), allophycocyanine (APC), or APC-Cy7 (BD Phar-
mingen). Typically, cells were first stained with 493-biotin followed
by streptavidin, a-CD23, a-B220, and a-IgM. For cell-transfer exper-
iments, cells were labeled prior to transfer for 15 min at 37C with
1025 M Cell Tracker Blue or 1026 M CFSE (Molecular Probes) in
serum-free media. Cells were analyzed on LSR, FACScaliber (BD
Pharmingen), or CYAN (Dako-Cytomation) flow cytometers.
For sorting, splenocytes were stained for 30 min in PBS + 1% FCS
on ice with 493-biotin. They were then washed and stained with SA-
APC-CY7, a-IgM (b-7-6 Fab Alexa 488), and a-CD23PE. Cells were
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multaneously (Dako-Cytomation). Sort purities were determined by
analysis of sorted populations on a CYAN flow cytometer and are
shown in Table S1.
Analysis of Calcium Mobilization
For measurements of free-intracellular-calcium concentration
([Ca2+]i), splenocytes were loaded with Indo-1AM (Molecular
Probes); labeled for CD93 with 493-biotin followed by SA-FITC,
a-CD23PE, and a-IgM (b-7-6 Fab alexa647); and resuspended at
43 106 cells/ml in IMDM; analysis was initiated with flow cytometry.
After the baseline was established, cells were stimulated with 2–
20 mg/ml rabbit anti-mouse IgM F(ab’)2 (Zymed). Mean [Ca
2+]i was
measured over time with an LSR flow cytometer and analyzed with
Flowjo software (Tree Star).
Stimulation and Assay of Protein Phosphorylation
Sorted splenic B cell populations were resuspended at a concentra-
tion of 106 cells in 25 ml of IMDM and incubated for 10 min at 37C
followed by stimulation for 3 min with 0.4 mg of rabbit anti-mouse
IgM F(ab’)2(Zymed). The immunoblot protocol has been described
previously (Benschop et al., 2001). Antiphosphotyrosine (4G10, Up-
state biotechnology), anti-phosphoErk1&2 (Cell Signaling), and anti-
Erk1&2 (Santa Cruz) were used. The anti-Dok and anti-phosphoDok
(Y295) rabbit antisera were made in our lab by using standard tech-
niques. Blots were quantitated by using NIH image.
Immunization
Igk2/2mice (Takeda et al., 1993) were immunized by immunoprecip-
itation (IP) injection of 100 mg of goat anti-mouse k light chains
(Bethyl Labs) in alum 1 week prior to tail-vein injection with 200 ml
of PBS containing 105 sorted mature follicular, T1, T2, or T3 B cells
and 1 mg of goat anti-mouse k light chains. Mice were reimmunized
by IP injection of an additional 100 mg of goat anti-mouse k light
chains in alum just after tail-vein injection. Mice were bled at 14
days, and the amount of k light chain containing immunoglobulin
was measured by enzyme-linked immunosorbent assay (ELISA).
In Vitro Induction and Assay of Antibody-Secreting Cells
Sorted B cell populations were cultured for 36 hr at 1 3 106 cells/ml
in medium containing LPS (10 mg/ml) to induce antibody secretion.
Numbers of viable cells in each culture were then determined by
counting with trypan-blue exclusion, and equal numbers of viable
cells were used for ELIspot assay as previously described (Czerkin-
sky et al., 1983). IgM-secreting and autoantigen-reactive-IgM-se-
creting cells were enumerated. For anti-ssDNA ELIspots, plates
were precoated with 0.1% poly-L-lysine and then 10 mg/ml sheared,
boiled-calf-thymus DNA. All buffers for the anti-ssDNA assay con-
tained 0.1 mM ethylenediamine tetra-acetic acid (EDTA). P values
were calculated with a two-tailed Student’s t test assuming equal
variance.
Gene-Expression Assays
B cell populations from C57BL6 splenocytes were sorted as outlined
above. a-HELtgHELtg, ArsA1, and a-HELtg splenocytes were
stained identically to the C57BL6 splenocytes, and CD23+ cells
were sorted. RNA was isolated from 3 3 106 sorted cells with the
Qiagen RNAeasy kit. Relative transcript expression was determined
by using Applied Biosystems high-capacity cDNA synthesis kits
and Taqman gene-expression assays. Relative expression was cal-
culated from the cycle threshold (cT) by the following formula:
2(cT(mature B cells) 2 cT(other B cells)). Relative amounts were then normal-
ized to relative Gapdh (glyceraldehydes phosphate dehydrogenase)
expression.
Supplemental Data
Supplemental Data include one table and two figures and are avail-
able with this article online at: http://www.immunity.com/cgi/
content/full/25/6/953/DC1/.
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